Trial intelligence / Profile preview

Comparison of 10% lidocaine spray in sniffing vs sitting position to reduce gag reflex during ERCP

TCTR20201125005Phase 1Not yet recruiting

Sponsor
Nakhon Pathom Hospital
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of lidocaine in pharyngeal reflex (2 arms), sponsored by Nakhon Pathom Hospital. Primary endpoint: Reduction in gag reflex response. Planned start Oct 2021; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

pharyngeal reflex

Beyond the preview

Go deeper on TCTR20201125005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20201125005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call